FORTRESS BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.75 USD | -3.31% |
|
-2.78% | -41.86% |
| Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
| Apr. 02 | Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024. | CI |
Chart calendar Fortress Biotech, Inc.
3d0ea314766d11696c45.Uz-1GCWjhqZokPihVQaMN-s4PIfvexUOWyJ4AJBzyuQ.GlbmXlzUts88qa71IGjTX7lyRcXYTmdhbWoNQ_MSq4MHfMBtaPzL5ALkmw~0a36a2d0858af68552d83299d1cc4a61
Upcoming events on Fortress Biotech, Inc.
Past events on Fortress Biotech, Inc.
| 2024-03-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-19 11:30 am | Roth Conference |
| 2024-03-18 05:00 pm | Roth Conference |
| 2023-11-14 04:10 pm | Q3 2023 Earnings Release |
| 2023-10-12 11:00 am | Roth Healtcare Opportunities Conference |
| 2023-10-09 | Reverse Split: 1 of 15 |
| 2023-10-09 10:00 am | Extraordinary Shareholders Meeting |
| 2023-09-12 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 04:01 pm | Q2 2023 Earnings Release |
| 2023-08-08 12:00 pm | BTIG Virtual Biotechnology Conference |
| 2023-06-21 10:00 am | Annual General Meeting |
| 2023-06-12 | Malignant Lymphoma International Conference |
| 2023-06-07 | European Hematology Association Hybrid Congress |
| 2023-05-15 04:01 pm | Q1 2023 Earnings Release |
| 2023-04-10 10:30 am | Extraordinary Shareholders Meeting |
| 2023-04-03 12:00 pm | Cantor The Future of Oncology Virtual Symposium |
| 2023-03-30 04:10 pm | Q4 2022 Earnings Release |
| 2023-03-15 12:40 pm | Oppenheimer Healthcare Conference |
| 2023-03-13 12:00 pm | ROTH Conference |
| 2023-02-18 11:00 am | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Abstract No - 82 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 36,6 36,6 0.1% | 45,6 44,1 3.49% | 68,8 95,0 -27.62% | 75,7 81,4 -6.92% | 84,5 79,7 6.07% | 71,2 |
|
EBITDA Million USD | Released Forecast Spread | -109 -104 -4.81% | -92,0 -93,1 1.19% | -189 -110 -71.71% | 0,00 0,00 - | 0,00 0,00 - | -168 |
|
EBIT Million USD | Released Forecast Spread | -111 -107 -3.86% | -94,3 -92,6 -1.79% | -189 -139 -35.23% | -204 -202 -0.75% | -142 -146 2.6% | -139 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -102 -83,9 -21.13% | -103 -94,8 -8.5% | -164 -96,3 -70.64% | -213 -213 -0.13% | -154 -153 -0.45% | -147 |
|
Net income Million USD | Released Forecast Spread | -40,0 -41,4 3.49% | -46,5 -52,4 11.23% | -64,7 -26,1 -147.8% | -86,6 -79,6 -8.74% | -68,7 -64,4 -6.59% | -98,1 |
|
EPS USD | Released Forecast Spread | -10,9 -10,8 -1.04% | -9,75 -10,9 10.47% | -11,8 -4,80 -146.87% | -14,5 -13,5 -8.02% | -8,47 -9,11 7.06% | -5,80 |
| Announcement Date | 16/03/20 | 31/03/21 | 28/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 18,3 44,5 -58.97% | 23,9 20,7 15.73% | 18,9 23,2 -18.53% | 16,5 21,6 -23.6% | 16,4 22,1 -25.62% | 12,4 20,3 -38.69% | 17,4 17,5 -0.45% | 34,5 15,9 117.16% | 20,6 15,1 36.26% | 14,1 | 15,3 | 24,0 | 17,8 |
|
EBITDA Million USD | Released Forecast Spread | -62,0 13,0 -576.93% | -47,3 -43,6 -8.42% | -50,9 -49,9 -2.06% | -50,7 -57,8 12.22% | -52,5 | -46,2 | -43,6 | -25,5 | |||||
|
EBIT Million USD | Released Forecast Spread | -62,0 -16,6 -273.97% | -47,3 -43,6 -8.42% | -50,9 -50,5 -0.83% | -50,7 -51,2 0.97% | -54,6 -53,1 -2.89% | -58,9 -53,0 -11.12% | -50,1 -56,3 11.07% | 17,2 -51,3 133.61% | -142 -38,0 -274.88% | -40,7 | -38,1 | -29,7 | -30,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,0 -12,6 -438.71% | -49,5 -42,6 -16.05% | -53,9 -49,8 -8.3% | -53,1 -55,1 3.76% | -57,0 -56,7 -0.49% | -55,1 -56,8 2.87% | -59,3 -60,0 1.23% | 16,9 -55,4 130.47% | -152 -42,2 -260.2% | -42,8 | -40,2 | -31,8 | -32,4 |
|
Net income Million USD | Released Forecast Spread | -31,6 7,02 -549.4% | -15,8 -19,3 18.23% | -21,4 -21,9 2.62% | -22,5 -26,7 15.84% | -26,9 -20,0 -34.86% | -21,5 -21,6 0.37% | -24,8 -23,8 -4.01% | 16,8 -23,4 171.71% | -67,0 -18,9 -254.78% | -28,7 | -26,4 | -23,8 | -19,2 |
|
EPS USD | Released Forecast Spread | -5,70 1,11 -613.51% | -2,70 -3,45 21.74% | -3,60 -3,60 0% | -3,75 -4,23 11.24% | -4,50 -3,33 -35.14% | -3,15 -3,20 1.56% | -3,36 -3,15 -6.67% | 0,80 -3,11 125.7% | -8,38 -1,65 -409.42% | -1,73 | -1,58 | -1,35 | -1,15 |
| Announcement Date | 28/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 07/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Fortress Biotech, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FBIO Stock
- Calendar Fortress Biotech, Inc.
